ArticleJournal of translational medicine2025

IDO1 inhibition enhances CLDN18.2-CAR-T cell therapy in gastrointestinal cancers by overcoming kynurenine-mediated metabolic suppression in the tumor microenvironment.

Zhaorong Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.